Analytical Data
-
基因名
MIF4GD
- Application
-
别名
MIF4GD；SLIP1；MIF4G domain-containing Protein
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
A9UHW6
-
表达区间
1-222aa
-
氨基酸序列
MGEPSREEYK IQSFDAETQQ LLKTALKDPG AVDLEKVANV IVDHSLQDCV FSKEAGRMCY AIIQAESKQA GQSVFRRGLL NRLQQEYQAR EQLRARSLQG WVCYVTFICN IFDYLRVNNM PMMALVNPVY DCLFRLAQPD SLSKEEEVDC LVLQLHRVGE QLEKMNGQRM DELFVLIRDG FLLPTGLSSL AQLLLLEIIE FRAAGWKTTP AAHKYYYSEV SD
-
分子量
25.4 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MIF4GD (Macrophage Migration Inhibitory Factor 4 Gene-Derived) is a protein that has garnered attention in recent years due to its potential role in various biological processes and diseases. Research has indicated that MIF4GD may play a significant part in immune response regulation, inflammation, and cellular signaling pathways. Its expression is often altered in pathological conditions, suggesting a possible involvement in cancer progression, autoimmune disorders, and metabolic diseases. Given the increasing prevalence of these diseases globally, understanding the functional mechanisms of MIF4GD is crucial for the development of novel therapeutic approaches. Moreover, recombinant expression of MIF4GD allows researchers to investigate its properties and interactions in detail, facilitating insights into its biological roles and potential as a biomarker or therapeutic target. The study of MIF4GD is emerging as a valuable avenue in molecular biology and medicine, promoting further exploration into its structure-function relationship and implications in health and disease.
